Source:http://linkedlifedata.com/resource/pubmed/id/15799397
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2005-3-31
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0047-1852
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
63 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
448-52
|
pubmed:dateRevised |
2011-7-27
|
pubmed:meshHeading |
pubmed-meshheading:15799397-Antirheumatic Agents,
pubmed-meshheading:15799397-Arthritis, Rheumatoid,
pubmed-meshheading:15799397-Humans,
pubmed-meshheading:15799397-Methotrexate,
pubmed-meshheading:15799397-Patient Care Management,
pubmed-meshheading:15799397-Patient Care Team,
pubmed-meshheading:15799397-Prognosis
|
pubmed:year |
2005
|
pubmed:articleTitle |
[Strategy for the management of RA patients].
|
pubmed:affiliation |
The Centre for Rheumatic Diseases, Matsuyama Red Cross Hospital.
|
pubmed:publicationType |
Journal Article,
Review
|